Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
US6391878B2 · kind B2 · utility
12Cited by
7References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2000 |
| Grant date | May 21, 2002 |
| Priority date | — |
| Expiry date | Dec 1, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/62
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention involves compounds having the following structure: as described in the Claims; and enantiomers, optical isomers, stereoisomers, diastereomers, tautomers, addition salts, biohydrolyzable amides and esters thereof, as well as pharmaceutical compositions comprising such novel compounds. The invention also relates to the use of such compounds for preventing or treating disorders modulated by alpha-2 adrenoceptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.